Last reviewed · How we verify
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
This is a double-center, single-arm, phase 2 study to evaluate the efficacy and safety of R-CDOP regimen combined with intrathecal methotrexate in chemo-naive diffuse large B-cell lymphoma patients with high-risk of CNS relapse.
Details
| Lead sponsor | Fudan University |
|---|---|
| Phase | PHASE2 |
| Status | RECRUITING |
| Enrolment | 83 |
| Start date | Sat Feb 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Dec 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Diffuse Large B-cell Lymphoma
Interventions
- R-CDOP+intrathecal MTX
Countries
China